ID: ALA4529283

Max Phase: Preclinical

Molecular Formula: C38H54N6O7

Molecular Weight: 706.89

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(N)=O

Standard InChI:  InChI=1S/C38H54N6O7/c1-25(2)23-30(43-34(47)29(24-26-15-8-6-9-16-26)42-33(46)27-17-10-7-11-18-27)36(49)44-22-14-20-31(44)35(48)41-28(32(39)45)19-12-13-21-40-37(50)51-38(3,4)5/h6-11,15-18,25,28-31H,12-14,19-24H2,1-5H3,(H2,39,45)(H,40,50)(H,41,48)(H,42,46)(H,43,47)/t28-,29-,30-,31-/m0/s1

Standard InChI Key:  XWXLSHDRGLBSMW-ORYMTKCHSA-N

Associated Targets(Human)

Fibroblast growth factor 14/SCN8A 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK293 82097 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Luciferin 4-monooxygenase 66902 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 706.89Molecular Weight (Monoisotopic): 706.4054AlogP: 3.21#Rotatable Bonds: 17
Polar Surface Area: 189.03Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.07CX Basic pKa: CX LogP: 3.22CX LogD: 3.22
Aromatic Rings: 2Heavy Atoms: 51QED Weighted: 0.16Np Likeness Score: -0.45

References

1. Liu Z, Wadsworth P, Singh AK, Chen H, Wang P, Folorunso O, Scaduto P, Ali SR, Laezza F, Zhou J..  (2019)  Identification of peptidomimetics as novel chemical probes modulating fibroblast growth factor 14 (FGF14) and voltage-gated sodium channel 1.6 (Nav1.6) protein-protein interactions.,  29  (3): [PMID:30587448] [10.1016/j.bmcl.2018.12.031]

Source